Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 16;10(7):53.
doi: 10.1038/s41389-021-00342-x.

Tumour heterogeneity and evolutionary dynamics in colorectal cancer

Affiliations
Review

Tumour heterogeneity and evolutionary dynamics in colorectal cancer

Dedrick Kok Hong Chan et al. Oncogenesis. .

Abstract

Colorectal cancer (CRC) has a global burden of disease. Our current understanding of CRC has progressed from initial discoveries which focused on the stepwise accumulation of key driver mutations, as encapsulated in the Vogelstein model, to one in which marked heterogeneity leads to a complex interplay between clonal populations. Current evidence suggests that an initial explosion, or "Big Bang", of genetic diversity is followed by a period of neutral dynamics. A thorough understanding of this interplay between clonal populations during neutral evolution gives insights into the roles in which driver genes may participate in the progress from normal colonic epithelium to adenoma and carcinoma. Recent advances have focused not only on genetics, transcriptomics, and proteomics but have also investigated the ecological and evolutionary processes which transform normal cells into cancer. This review first describes the role which driver mutations play in the Vogelstein model and subsequently demonstrates the evidence which supports a more complex model. This article also aims to underscore the significance of tumour heterogeneity and diverse clonal populations in cancer progression.

PubMed Disclaimer

Conflict of interest statement

SJAB is supported by The Pharsalia Trust, as well as a Cancer Research UK Advanced Clinician Scientist Fellowship (C14094/A27178). DKHC is supported by the Singapore Ministry of Health’s National Medical Research Council under a Research Training Fellowship (MOH-FLWSHP19may-0001).

Figures

Fig. 1
Fig. 1. Representative dendrogram showing differences in the distribution of mutations in premalignant lesions, and cancer.
In (a) premalignant lesions, the trunk tends to be shorter with multiple branches, suggesting the presence of multiple subclones. In (b) cancer, the trunks are longer, demonstrating that cancer cells tend to be clonal. These dendrograms are adapted from Cross et al. [43].
Fig. 2
Fig. 2. Two different evolutionary models are presented here, with each colour representing a subclonal population.
In (a) the big bang model, multiple subclonal populations are seen early and followed by a period of neutral evolution. In (b) the Darwinian model, subclones with a selective advantage outgrow other subclones.

References

    1. Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16:713–32. doi: 10.1038/s41575-019-0189-8. - DOI - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. doi: 10.3322/caac.21492. - DOI - PubMed
    1. Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019;4:511–8. doi: 10.1016/S2468-1253(19)30147-5. - DOI - PMC - PubMed
    1. Fidler MM, Soerjomataram I, Bray F. A global view on cancer incidence and national levels of the human development index. Int J Cancer. 2016;139:2436–46. doi: 10.1002/ijc.30382. - DOI - PubMed
    1. Chatenoud L, Bertuccio P, Bosetti C, Levi F, Curado MP, Malvezzi M, et al. Trends in cancer mortality in Brazil, 1980–2004. Eur J Cancer Prev. 2010;19:79–86. doi: 10.1097/CEJ.0b013e32833233be. - DOI - PubMed